Press releases
Your source for Evernorth news.
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Estimated to save individual Accredo patients around $4,000 per year
Biosimilar price will be more than 80% lower than Stelara list price
Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (50)
Press Release
Evernorth’s Accredo Earns URAC Rare Disease Pharmacy Center of Excellence Designation
February 10, 2022
Press Release
Pharmacists’ Role to Expand Over Next Decade amid the Pandemic and Provider Shortages
January 12, 2022
Nearly 80% of patients see pharmacists as a key component of their health care team. To meet growing demand and fill gaps in care, more advanced training for pharmacists in areas such as chronic disease management, diagnosis and prescribing will be a key focus
Press Release
Behavioral Health Treatment Helps Reduce Total Cost of Care, New Evernorth Analysis Finds
November 16, 2021
First-of-its-kind analysis proves medical and pharmacy costs can decrease by more than $3,000 over two years when people receive outpatient behavioral health care.
Press Release
Express Scripts Creates Industry-First Solution to Provide Coverage for At-Home COVID-19 Test Kits
November 10, 2021
New offering will help employers and health plans support their employees’ wellbeing with expanded, affordable access to testing options under their pharmacy benefit
Press Release
State of West Virginia Selects Express Scripts to Bring Affordability to PEIA Pharmacy Benefit Program
November 08, 2021
Three-Year Agreement Covers 165,000 State Employees
Press Release
Express Scripts Will Unlock $20 Million in Savings for Clients in 2022 by Preferring the First Interchangeable Insulin Biosimilar
October 20, 2021